GILD Gilead Sciences Inc

Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.

$69.53  -0.15 (-0.21%)
As of 12/03/2021 15:59:58 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  USA
Country of incorporation:  USA
IPO date:  02/20/2001
Outstanding shares:  1,254,383,522
Average volume:  7,240,219
Market cap:   $87,392,899,978
Current dividend yield:  3.97%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    375558103
ISIN:        US3755581036
Sedol:      2369174
Valuation   (See tab for details)
PE ratio:   11.80
PB ratio:   4.07
PS ratio:   3.18
Return on equity:   34.44%
Net income %:   26.90%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy